Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Islet Cell Top-up vs Transplantation

<< Previous

Bullboard Posts

Next >>

Comment by hoffbagon May 26, 2021 12:51pm

109 Views

Post# 33268291

RE:Islet Cell Top-up vs Transplantation

I am still learning (as Biotek will attest to) but I find this perplexing. The cell pouch is supposed to be the transplant device. So why not use it for the additional islets. Going forward, is it just a matter of adjusting volumes in the cell pouch on the first take or is "topping up" (which is kind of an understatement) a necessary course of action.
Hopefully they will better explain "topping up" in the future.

<< Previous

Bullboard Posts

Next >>

As AI expands, where can investors look for strong growth?